The packaging of dMEGA3 has been renewed with a more modern, immediate and recognizable look

The packaging of dMEGA3 has been renewed with a more modern, immediate and recognizable look

World leishmaniosis day! Pharmacross supports veterinarians in their daily battle against this disease. If not treated, canine leishmaniosis is a potentially fatal zoonotic disease . Pharmacross, with its LeisIMMUNE, offers a product that supports the dog’s immune response, thanks to its content in nucleotides and lactoferrin. Pharmacross: always EBVM, always with Vets, always with pets.

Great success at this year’s edition of the Montenegro International Veterinary Congress,  promoted by Hospital Referência Veterinária Montenegro.

We are thrilled to announce the launch of LeisIMMUNE BOOST, a cutting-edge product designed to support the immune system of dogs suffering from canine leishmaniosis (CanL).

Pharmacross, together with SIA Universitates Vetfonds, took part in the Nephrology Seminar at the Faculty of Veterinary Medicine in Latvia, strengthening its connection with the veterinary community.

We are glad to announce the launch of Pharmacross products in Greece, in partnership with Pharmacell S.A. Animal Health Care & Nutrition

Pharmacross expands its international presence by launching in Cyprus through a new partnership with SOUZANA SAVVIDOU LTD, a leading distributor of veterinary health and care products.

Despite the challenges of 2020, Pharmacross achieved significant international growth, expanding its distribution network to nine countries with the addition of Cyprus, Greece, and Portugal. The company celebrates this important milestone and thanks its partners and customers for their continued trust and support, looking forward to a successful 2021.

Pharmacross announces an exclusive distribution agreement with Dr. Nelson Lemos Cardoso Loureiro to commercialize its full product portfolio in Portugal. Combining Pharmacross’ innovative veterinary solutions with Dr. Loureiro’s expertise in small animal medicine and orthopedics, this partnership marks an important step in expanding the company’s presence in the Portuguese veterinary market.